Boston Scientific Corporation (BSX)

NYSE: BSX · Real-Time Price · USD

46.84

+0.17 (0.36%)

At close: Aug 28, 2026, 4:00 PM EDT

46.85

+0.01 (0.02%)

After-hours: Aug 28, 2026, 7:59 PM EDT

Boston Scientific Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	539	1,965	414	865	928	1,925
Cash & Short-Term Investments	539	1,965	414	865	928	1,925
Cash Growth	0.94%	374.64%	-52.14%	-6.79%	-51.79%	11.02%
Accounts Receivable	3,049	2,926	2,558	2,228	1,970	1,778
Receivables	3,049	2,926	2,558	2,228	1,970	1,778
Inventory	3,235	2,943	2,810	2,484	1,867	1,610
Restricted Cash	81	80	111	130	149	188
Other Current Assets	1,068	880	1,027	807	846	816
Total Current Assets	7,972	8,794	6,920	6,514	5,760	6,317
Property, Plant & Equipment	4,679	4,501	3,743	3,298	2,832	2,687
Long-Term Investments	2,245	682	555	413	407	411
Goodwill	18,640	18,282	17,089	14,387	12,920	11,988
Other Intangible Assets	6,918	7,019	6,684	6,003	5,969	6,235
Long-Term Deferred Tax Assets	3,909	3,675	3,655	3,841	3,942	4,142
Other Long-Term Assets	853	720	749	680	639	449
Total Assets	45,216	43,673	39,395	35,136	32,469	32,229

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1,231	1,144	960	942	862	794
Accrued Expenses	2,756	3,201	2,773	2,136	1,855	1,883
Current Portion of Long-Term Debt	1,709	299	1,778	531	20	261
Current Portion of Leases	-	90	81	76	61	71
Current Income Taxes Payable	-	-	-	220	232	209
Current Unearned Revenue	-	313	306	266	220	208
Other Current Liabilities	732	392	501	762	553	848
Total Current Liabilities	6,428	5,439	6,399	4,933	3,803	4,274
Long-Term Debt	10,791	11,012	8,842	8,566	8,910	8,798
Long-Term Leases	124	571	527	395	352	395
Long-Term Unearned Revenue	-	369	329	311	289	276
Long-Term Deferred Tax Liabilities	221	220	155	134	144	310
Other Long-Term Liabilities	2,480	1,590	1,140	1,267	1,398	1,554
Total Liabilities	20,044	19,201	17,392	15,606	14,896	15,607

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	17	17	17	17	17	17
Additional Paid-In Capital	21,717	21,505	21,056	20,647	20,289	19,986
Retained Earnings	7,818	5,571	2,673	819	-750	-1,392
Treasury Stock	-4,318	-2,251	-2,251	-2,251	-2,251	-2,251
Comprehensive Income & Other	-304	-609	275	50	268	262
Total Common Equity	24,930	24,233	21,770	19,282	17,573	16,622
Minority Interest	242	239	233	248	-	-
Shareholders' Equity	25,172	24,472	22,003	19,530	17,573	16,622
Total Liabilities & Equity	45,216	43,673	39,395	35,136	32,469	32,229

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	12,624	11,972	11,228	9,568	9,343	9,525
Net Cash (Debt)	-12,085	-10,007	-10,814	-8,703	-8,415	-7,600
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-8.11	-6.70	-7.28	-5.95	-5.84	-5.30
Filing Date Shares Outstanding	1,449	1,484	1,476	1,467	1,435	1,427
Total Common Shares Outstanding	1,447	1,483	1,475	1,466	1,433	1,426
Working Capital	1,544	3,355	521	1,581	1,957	2,043
Book Value Per Share	17.23	16.34	14.76	13.16	12.26	11.66
Tangible Book Value	-628	-1,068	-2,003	-1,108	-1,316	-1,601
Tangible Book Value Per Share	-0.43	-0.72	-1.36	-0.76	-0.92	-1.12
Land	183	173	144	140	137	109
Buildings	2,715	2,485	2,018	1,843	1,695	1,523
Machinery	4,045	3,827	3,630	3,503	3,298	3,288
Construction In Progress	911	1,161	1,035	857	598	605

SEC Filings: 10-K · 10-Q